Neuropore Therapies

About:

San Diego-based Neuropore, a biopharmaceuticals firm developing treatments for Parkinson's disease.

Website: http://www.neuropore.com/

Twitter/X: Neuropore_news

Top Investors: Michael J. Fox Foundation, The ALS Association

Description:

Neuropore Therapies is a pharmaceutical company located in San Diego, CA committed to the discovery and development of disease-modifying treatments for neurodegenerative disorders, including Parkinson’s disease and Alzheimer’s disease. They are located on Road to the Cure in San Diego, CA.Their approach is based on the fundamental concept that the pathological accumulation of misfolded and aggregated neurotoxic proteins is the underlying basis of these disorders. Their therapeutic candidates directly target these proteins and restore cellular autophagy mechanisms to degrade and dispose of these neurotoxic proteins.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2008-01-01

Founders:

Edward Rockenstein, Wolf Wrasidlo

Number of Employees:

11-50

Last Funding Date:

2020-02-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai